MedPath

Cefditoren

Generic Name
Cefditoren
Brand Names
Spectracef
Drug Type
Small Molecule
Chemical Formula
C19H18N6O5S3
CAS Number
104145-95-1
Unique Ingredient Identifier
81QS09V3YW

Overview

Cefditoren is an oral third-generation cephalosporin. It is commonly marketed under the trade name Spectracef by Cornerstone BioPharma.

Background

Cefditoren is an oral third-generation cephalosporin. It is commonly marketed under the trade name Spectracef by Cornerstone BioPharma.

Indication

For the treatment of mild to moderate infections in adults and adolescents (12 years of age or older) which are caused by susceptible strains of microorganisms in acute bacterial exacerbation of chronic bronchitis, community-acquired pneumonia, pharyngitis/tonsillitis, and uncomplicated skin and skin-structure infections.

Associated Conditions

  • Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB)
  • Bacterial Infections
  • Community Acquired Pneumonia (CAP)
  • Streptococcal Pharyngitis
  • Tonsillitis streptococcal
  • Uncomplicated skin and subcutaneous tissue bacterial infections

FDA Approved Products

Cefditoren Pivoxil
Manufacturer:Pharma RomLev Inc.
Route:ORAL
Strength:200 mg in 1 1
Approved: 2013/02/19
NDC:44009-801
Cefditoren Pivoxil
Manufacturer:Pharma RomLev Inc.
Route:ORAL
Strength:400 mg in 1 1
Approved: 2013/02/19
NDC:44009-802
Spectracef
Manufacturer:Vansen Pharma Inc.
Route:ORAL
Strength:200 mg in 1 1
Approved: 2013/02/19
NDC:44004-801
Spectracef
Manufacturer:Vansen Pharma Inc.
Route:ORAL
Strength:400 mg in 1 1
Approved: 2013/02/19
NDC:44004-802

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath